These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17341023)

  • 41. Design, synthesis, and thrombin-inhibitory activity of pyridin-2-ones as P2/P3 core motifs.
    Hanessian S; Simard D; Bayrakdarian M; Therrien E; Nilsson I; Fjellström O
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1972-6. PubMed ID: 18289852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystal structure of the thrombin mutant D221A/D222K: the Asp222:Arg187 ion-pair stabilizes the fast form.
    Pineda AO; Zhang E; Guinto ER; Savvides SN; Tulinsky A; Di Cera E
    Biophys Chem; 2004 Dec; 112(2-3):253-6. PubMed ID: 15572256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.
    Dementiev A; Petitou M; Herbert JM; Gettins PG
    Nat Struct Mol Biol; 2004 Sep; 11(9):863-7. PubMed ID: 15311268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitors.
    Schweizer E; Hoffmann-Röder A; Olsen JA; Seiler P; Obst-Sander U; Wagner B; Kansy M; Banner DW; Diederich F
    Org Biomol Chem; 2006 Jun; 4(12):2364-75. PubMed ID: 16763681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors.
    Howard N; Abell C; Blakemore W; Chessari G; Congreve M; Howard S; Jhoti H; Murray CW; Seavers LC; van Montfort RL
    J Med Chem; 2006 Feb; 49(4):1346-55. PubMed ID: 16480269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of ligand and protein desolvation on ligand binding to the S1 pocket of thrombin.
    Biela A; Khayat M; Tan H; Kong J; Heine A; Hangauer D; Klebe G
    J Mol Biol; 2012 May; 418(5):350-66. PubMed ID: 22366545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase.
    Gould WR; Cladera E; Harris MS; Zhang E; Narasimhan L; Thorn JM; Leadley RJ
    Biochemistry; 2005 Jul; 44(26):9280-9. PubMed ID: 15981994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structures of potent selective peptide mimetics bound to carboxypeptidase B.
    Adler M; Buckman B; Bryant J; Chang Z; Chu K; Emayan K; Hrvatin P; Islam I; Morser J; Sukovich D; West C; Yuan S; Whitlow M
    Acta Crystallogr D Biol Crystallogr; 2008 Feb; 64(Pt 2):149-57. PubMed ID: 18219114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular recognition of carbohydrates with artificial receptors: mimicking the binding motifs found in the crystal structures of protein-carbohydrate complexes.
    Mazik M; Cavga H; Jones PG
    J Am Chem Soc; 2005 Jun; 127(25):9045-52. PubMed ID: 15969582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor.
    Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1227-33. PubMed ID: 15504346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design.
    Krajewski WW; Collins R; Holmberg-Schiavone L; Jones TA; Karlberg T; Mowbray SL
    J Mol Biol; 2008 Jan; 375(1):217-28. PubMed ID: 18005987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Crystallographic determination of thrombin complexes with small synthetic inhibitors as a starting point for the receptor-based design of antithrombotics.
    Bauer M; Brandstetter H; Turk D; Stürzebecher J; Bode W
    Semin Thromb Hemost; 1993; 19(4):352-60. PubMed ID: 8140427
    [No Abstract]   [Full Text] [Related]  

  • 53. Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility.
    Silvaggi NR; Boldt GE; Hixon MS; Kennedy JP; Tzipori S; Janda KD; Allen KN
    Chem Biol; 2007 May; 14(5):533-42. PubMed ID: 17524984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crystal and electronic structures of magnesium(II), copper(II), and mixed magnesium(II)-copper(II) complexes of the quinoline half of styrylquinoline-type HIV-1 integrase inhibitors.
    Courcot B; Firley D; Fraisse B; Becker P; Gillet JM; Pattison P; Chernyshov D; Sghaier M; Zouhiri F; Desmaële D; d'Angelo J; Bonhomme F; Geiger S; Ghermani NE
    J Phys Chem B; 2007 May; 111(21):6042-50. PubMed ID: 17488111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of structural-kinetic and structural-thermodynamic relationships for thrombin inhibitors.
    Winquist J; Geschwindner S; Xue Y; Gustavsson L; Musil D; Deinum J; Danielson UH
    Biochemistry; 2013 Jan; 52(4):613-26. PubMed ID: 23290007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at P1.
    Krishnan R; Mochalkin I; Arni R; Tulinsky A
    Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):294-303. PubMed ID: 10713516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stability.
    Staas DD; Savage KL; Sherman VL; Shimp HL; Lyle TA; Tran LO; Wiscount CM; McMasters DR; Sanderson PE; Williams PD; Lucas BJ; Krueger JA; Lewis SD; White RB; Yu S; Wong BK; Kochansky CJ; Anari MR; Yan Y; Vacca JP
    Bioorg Med Chem; 2006 Oct; 14(20):6900-16. PubMed ID: 16870455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A series of natural flavonoids as thrombin inhibitors: structure-activity relationships.
    Liu L; Ma H; Yang N; Tang Y; Guo J; Tao W; Duan J
    Thromb Res; 2010 Nov; 126(5):e365-78. PubMed ID: 20828797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative study of the single crystal X-ray determination and molecular modelling of the binding of oligomycin to ATP synthase.
    Green RC; Thumser AE; Povey D; Saldanha JW; Potter BS; Palmer RA; Howlin BJ
    Comput Biol Chem; 2009 Jun; 33(3):189-95. PubMed ID: 19217349
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crystal structure of thrombin in complex with fibrinogen gamma' peptide.
    Pineda AO; Chen ZW; Marino F; Mathews FS; Mosesson MW; Di Cera E
    Biophys Chem; 2007 Feb; 125(2-3):556-9. PubMed ID: 16962697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.